Regulation 2019/6 on veterinary medicinal products lays down that the Commission shall adopt tertiary legislation to set up criteria for the designation of antimicrobials reserved for treatment of certain infections in humans. FVE has sent its inputs to the EU Institutions and to the European Medicines Agency. Through its input paper FVE restates that banning is not a solution for animal health care nor the miracle to reduce the human antimicrobial burden.

To combat antimicrobial resistance (AMR), there is the need to continue working on Reduction, Replacement and the Re-thinking of the use of antimicrobials in animals and humans.